{{Rsnum
|rsid=11643630
|Chromosome=16
|position=55476547
|Orientation=plus
|GMAF=0.4775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 43.4 | 43.4 | 13.3
| HCB | 17.5 | 46.7 | 35.8
| JPT | 13.3 | 47.8 | 38.9
| YRI | 18.4 | 44.9 | 36.7
| ASW | 15.8 | 57.9 | 26.3
| CHB | 17.5 | 46.7 | 35.8
| CHD | 15.6 | 58.7 | 25.7
| GIH | 47.5 | 43.6 | 8.9
| LWK | 18.2 | 52.7 | 29.1
| MEX | 27.6 | 50.0 | 22.4
| MKK | 25.0 | 52.6 | 22.4
| TSI | 28.4 | 52.0 | 19.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19454611
|Title=Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility
|OA=1
}}

{{PMID Auto
|PMID=20222942
|Title=Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}